| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [589] [590] [591] 592 [593] [594] [595] [596] Next Page Last Page Total 17946 items, Total 718 Page Goto
| 2A-3183061 |
Bremelanotide (Acetate) |
1607799-13-2 |
|
0% |
Inquiry |
| 2A-3183062 |
Sermorelin |
114466-38-5 |
|
0% |
Inquiry |
| 2A-3183071 |
2,5-DIMETHOXY-BETA-NITROSTYRENE |
40276-11-7 |
|
0% |
Inquiry |
| 2A-3183072 |
Isosorbide Mononitrate, Diluted |
2A-3183072 |
|
0% |
Inquiry |
| 2A-3183073 |
Clarithromycin Lactobionate |
135326-55-5 |
|
0% |
Inquiry |
| 2A-3183074 |
Esmolo Hydrochloride |
2A-3183074 |
|
0% |
Inquiry |
| 2A-3183075 |
Ox Bile Power |
2A-3183075 |
|
0% |
Inquiry |
| 2A-3183076 |
Pig Bile Powder |
2A-3183076 |
|
0% |
Inquiry |
| 2A-3183077 |
Oxirane, 2,2'-[[4,6-bis(tricyclo[3.3.1.13,7]dec-1-yl)-1,3-phenylene]bis(oxyMethy |
1030386-18-5 |
|
0% |
Inquiry |
| 2A-3183077 |
Oxirane, 2,2'-[[4,6-bis(tricyclo[3.3.1.13,7]dec-1-yl)-1,3-phenylene]bis(oxyMethy |
1030386-18-5 |
|
0% |
Inquiry |
| 2A-3183078 |
3-Methyl-1-adamantanol |
702-81-8 |
|
0% |
Inquiry |
| 2A-3183078 |
3-Methyl-1-adamantanol |
702-81-8 |
|
0% |
Inquiry |
| 2A-3183078 |
3-Methyl-1-adamantanol |
702-81-8 |
|
0% |
Inquiry |
| 2A-3183079 |
3-ETHYL-1-ADAMANTANOL |
15598-87-5 |
|
0% |
Inquiry |
| 2A-3183080 |
2-CHLOROADAMANTANE |
7346-41-0 |
|
0% |
Inquiry |
| 2A-3183081 |
Sulglycotide |
54182-59-1 |
|
0% |
Inquiry |
| 2A-3183082 |
CHONDROITIN SULFATE SODIUM |
2A-3183082 |
|
0% |
Inquiry |
| 2A-3183083 |
LITHOSPERMUM EXTRACT |
2A-3183083 |
|
0% |
Inquiry |
| 2A-3183088 |
FMOC-Amino Acids |
2A-3183088 |
|
0% |
Inquiry |
| 2A-3183089 |
L-citrulline-malic acid |
2A-3183089 |
|
0% |
Inquiry |
| 2A-3183090 |
Proglycol dipeptide |
2A-3183090 |
|
0% |
Inquiry |
| 2A-3183093 |
L-arginine-malic acid |
2A-3183093 |
|
0% |
Inquiry |
| 2A-3183094 |
D-isoisoleucine |
2A-3183094 |
|
0% |
Inquiry |
| 2A-3183095 |
Nisilidide |
2A-3183095 |
|
0% |
Inquiry |
| 2A-3183097 |
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanaMide |
241479-75-4 |
|
0% |
Inquiry |
| |
|
|
|
